Characterization of peripheral blood stem cell grafts mobilized by G-CSF and plerixafor in comparison to G-CSF alone

被引：0

作者：

Gaugler, B. ^{[1
]}

Arbez, J. ^{[1
]}

Frikeche, J. ^{[2
]}

Le Gouill, S. ^{[3
]}

Gastinne, T. ^{[3
]}

Blin, N. ^{[3
]}

Chevallier, P. ^{[3
]}

Guillaume, T. ^{[3
]}

Delaunay, J. ^{[3
]}

Ayari, S. ^{[3
]}

Rialland, F. ^{[3
]}

Mahe, B. ^{[3
]}

Dubruille, V. ^{[3
]}

Clavert, A. ^{[3
]}

Rolland, V. ^{[3
]}

Saas, P. ^{[1
]}

Moreau, P. ^{[3
]}

Derenne, S. ^{[4
]}

Mohty, M. ^{[3
]}

机构：

[1] INSERM, U645, Besancon, France

[2] INSERM, U892, Nantes, France

[3] CHU Hotel Dieu, Nantes, France

[4] EFS Pays de Loire, Nantes, France

来源：

BONE MARROW TRANSPLANTATION | 2011年 / 46卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：S61 / S62

页数：2

共 50 条

[41] SERUM G-CSF LEVELS IN PATIENTS UNDERGOING G-CSF CHEMOTHERAPY MOBILIZED PERIPHERAL STEM-CELL HARVEST AND PREDICTORS OF NEUTROPHIL AND PLATELET RECOVERY
MAHARAJ, D
GOMEZMARIN, O
LEWISXIMENEZ, LL
RILEY, R
ALBARRACIN, C
LEUKEMIA, 1995, 9 : S113 - S117
[42] Plerixafor and G-CSF for autologous stem cell mobilization in AL amyloidosis
Kaul, E.
Shah, G.
Chaulagain, C.
Comenzo, R. L.
BONE MARROW TRANSPLANTATION, 2014, 49 (09) : 1233 - 1233
[43] OPTIMAL PERIPHERAL-BLOOD STEM-CELL (PBSC) MOBILIZATION WITH GM-CSF OR G-CSF NECESSITATES CHEMOTHERAPY PRIMING - A STUDY OF GM-CSF OR G-CSF ALONE COMPARED TO GM-CSF OR G-CSF PLUS CYTOXAN (CY)
KOUIDES, PA
ABBOUD, CN
KOUIDES, RW
FREDIANI, KE
BELANGER, T
DIPERSIO, JF
BLOOD, 1993, 82 (10) : A634 - A634
[44] Cyclophosphamide or plerixafor and G-CSF for stem cell mobilization: initial cost comparison analysis
Jagasia, M.
Pickard, S.
Chen, H.
Dixon, S.
Savani, B.
BONE MARROW TRANSPLANTATION, 2010, 45 : S24 - S24
[45] Failure of adequate mobilization of peripheral blood progenitor cell (PBPC) with chemotherapy and G-CSF:: G-CSF alone is superior to chemotherapy plus G-CSF for 2nd mobilization.
Fraipont, V
Sautois, B
Baudoux, E
Pereira, M
Fassotte, MF
Jerusalem, G
Hermanne, JP
Longrée, L
Schaaf-Lafontaine, N
Sondag, D
Fillet, G
Beguin, Y
BLOOD, 1998, 92 (10) : 268A - 268A
[46] Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma
DiPersio, John F.
Stadtmauer, Edward A.
Nademanee, Auayporn
Micallef, Ivana N. M.
Stiff, Patrick J.
Kaufman, Jonathan L.
Maziarz, Richard T.
Hosing, Chitra
Frueehauf, Stefan
Horwitz, Mitchell
Cooper, Dennis
Bridger, Gary
Calandra, Gary
BLOOD, 2009, 113 (23) : 5720 - 5726
[47] Plerixafor plus G-CSF (P plus G) compared with G-CSF alone (G) for hematopoietic progenitor cell (HPC) mobilization in AL amyloidosis (AL).
Dhakal, Binod
Strouse, Christopher Sun
Arce-Lara, Carlos
D'souza, Anita
Esselman, Jean
Eastwood, Daniel
Pasquini, Marcelo C.
Saber, Wael
Drobyski, William R.
Hari, Parameswaran
Hamadani, Mehdi
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[48] Diabetes Limits Stem Cell Mobilization Following G-CSF but Not Plerixafor
Fadini, Gian Paolo
Fiala, Mark
Cappellari, Roberta
Danna, Marianna
Park, Soo
Poncina, Nicol
Menegazzo, Lisa
Albiero, Mattia
DiPersio, John
Stockerl-Goldstein, Keith
Avogaro, Angelo
DIABETES, 2015, 64 (08) : 2969 - 2977
[49] A prospective comparison of cytokines alone for peripheral blood progenitor cell collection in patients with advanced gynaecological malignancies: G-CSF versus G-CSF plus EPO
Perillo, A
Ferrandina, G
Pierelli, L
Rutella, S
Bonanno, G
Gallottal, V
Paglia, A
Mariotti, A
Mancuso, S
Scambia, G
EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) : 132 - 132
[50] PLATELET AND NEUTROPHIL RECOVERY FOLLOWING AUTOTRANSPLANT WITH G-CSF PRIMED MARROW OR G-CSF MOBILIZED BLOOD IS NOT DIFFERENT
JANSSEN, WE
SMILEE, RC
PERKINS, J
FIELDS, J
HIEMENZ, KK
ZORSKY, JW
BALLESTER, PE
GOLDSTEIN, OF
KRONISH, SC
BEACH, B
ELFENBEIN, GJ
EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 863 - 863

← 1 2 3 4 5 →